Articles tagged "Survival"

2020 American Transplant Congress
Transplant Center Effect on Acute Liver Failure Outcomes in a National Cohort
N. Z. Wong, K. R. Reddy, T. Bittermann
University of Pennsylvania, Philadelphia, PA
*Purpose: Transplant centers coordinate complex care for patients with acute liver failure (ALF), in whom liver transplantation (LT) can be lifesaving. This study examines associations…
2020 American Transplant Congress
Perioperative Extracorporeal Membrane Oxygenation (ECMO) in Liver Transplantation: A Case Series
J. G. Guorgui¹, T. Ito¹, M. M. Lu¹, P. Benharash², A. Ardehali³, V. Gudzenko⁴, C. Wray⁴, V. G. Agopian¹, J. DiNorcia III¹, H. Yersiz¹, D. G. Farmer¹, R. W. Busuttil¹, F. M. Kaldas¹
¹The Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA, ²Cardiovascular Outcomes Research Laboratories, UCLA, Los Angeles, CA, ³Division of Cardiac Surgery, Department of Surgery, UCLA, Los Angeles, CA, ⁴Department of Anesthesiology, UCLA, Los Angeles, CA
*Purpose: Extracorporeal Membrane Oxygenation (ECMO) is a life-saving treatment modality for patients who develop cardiopulmonary failure refractory to conventional efforts. ECMO has been used sparingly…
2019 American Transplant Congress
A Comprehensive and Updated Analysis of Combined Heart-Kidney Transplants Utilizing the United Network for Organ Sharing Database
V. M. Lim¹, N. Khurmi¹, W. R. Hewitt, Jr.², A. K. Mathur², O. E. Pajaro³, D. E. Jaroszewski³, B. D. Gaitan¹
¹Anesthesiology, Mayo Clinic Arizona, Phoenix, AZ, ²Transplantation Surgery, Mayo Clinic Arizona, Phoenix, AZ, ³Cardiovascular and Thoracic Surgery, Mayo Clinic Arizona, Phoenix, AZ
*Purpose: Analysis of combined heart-kidney transplants (HKTx) reveals equivalent or improved patient survival and reduced allograft rejection rates as compared to single-organ transplants. The rate…
2019 American Transplant Congress
Treatment Modality Affects Outcomes of Recurrent Hepatocellular Carcinoma Following Liver Transplantation: A US Multicenter Analysis of 2786 Patients
P. Tabrizian¹, K. J. Halazun², M. L. Holzner¹, N. Mehta³, F. Y. Yao³, J. Roberts³, J. C. Emond⁴, B. Samstein², R. S. Brown⁴, S. Florman¹, M. E. Schwartz¹, M. M. Doyle⁵, W. C. Chapman⁵, M. Najjar⁴, R. W. Busuttil⁶, V. G. Agopian⁶
¹Transplant, Mount Sinai Medical Center, New York, NY, ²Transplant, Weill Cornell Medicine, New York, NY, ³Transplant, University of California San Francisco, San Francisco, CA, ⁴Transplant, Columbia University Medical Center, New York, NY, ⁵Transplant, Washington University School of Medicine, St Louis, MO, ⁶Transplant, David Geffen School of Medicine at UCLA, Los Angeles, CA
*Purpose: Recurrent hepatocellular carcinoma (HCC) following liver transplantation (LT) has a poor prognosis. We evaluated the impact of treatment modalities on post-recurrence survival.*Methods: Adult patients…
2019 American Transplant Congress
Prognostic Value Of Dobutamine Stress Echocardiography In Heart Transplantation Recipients
A. Singhvi, R. Araujo-Gutierrez, M. H. Park, A. Bhimaraj, B. H. Trachtenberg, I. Hussain, A. Guha
Division of Cardiology/ JC Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, TX
*Purpose: Dobutamine stress echocardiography (DSE) carries a class IIa recommendation in the ISHLT guidelines for screening of cardiac allograft vasculopathy (CAV). Positive DSEs have a…
2019 American Transplant Congress
Diastolic Blood Pressure Derived from Twenty Four Hour Ambulatory Blood Pressure Monitoring Predicts Survival after Kidney Transplantation
l. Basdeo, H. Wadei, M. Prendergast, M. Mai, C. Oshel, T. Jarmi
Transplant, Mayo Clinic, Jacksonville, FL
*Purpose: Cardiac events remain the leading, long term, cause of death after kidney transplantation. In the general population, 50% of cardiac events are attributed to…
2019 American Transplant Congress
Clinical Presentation After Hepatitis B Recurrence In Liver Transplant Patients
W. Lee, C. Cheng, T. Wu, Y. Wang, C. Lee, T. Wu, H. Chou, K. Chan
Chang-Gung Hospital, Taoyuan, Taiwan
*Purpose: Combination of anti-hepatitis B immunoglobulin and antiviral agents is the standard care for prophylaxis of hepatitis B virus (HBV) recurrence after liver transplantation. However,…
2019 American Transplant Congress
What Are You Smoking? The Impact of Donor Drug Use on Long Term Survival Post-Transplant
D. A. Baran¹, A. Long¹, J. T. Lansinger², H. Copeland³, J. M. Herre¹, W. Old¹, G. Zeevi¹, C. Barreiro¹, C. Kemp¹, B. H. Smith¹, K. Stelling¹, A. Ingemi¹, P. Bourassa¹, J. Philpott¹
¹Sentara Heart Hospital, Norfolk, VA, ²Eastern Virginia Medical School, Norfolk, VA, ³Division of Cardiothoracic Surgery, University of Mississippi Medical Center, Jackson, MS
*Purpose: Drug use is a common aspect in the history of heart transplant donors. Whether prior or current drug use is associated with inferior post…
2019 American Transplant Congress
Effect of Chronic Kidney Disease on Allo-Immune Response in Mice
P. D. Winterberg¹, H. Li¹, M. E. Wagener², M. L. Ford²
¹Pediatrics, Emory University School of Medicine, Atlanta, GA, ²Surgery, Emory University School of Medicine, Atlanta, GA
*Purpose: Accumulation of memory T cells bearing markers of sustained antigen stimulation have been described in patients with chronic kidney disease (CKD). However, mouse models…
2019 American Transplant Congress
Influence Of HLA-DR Mismatches On Long Term Outcomes Following Heart Transplantation
A. Singhvi, R. Araujo-Gutierrez, M. H. Park, A. Bhimaraj, B. H. Trachtenberg, I. Hussain, A. Guha
Division of Cardiology/ JC Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, TX
*Purpose: In the field of kidney transplantation, there is strong support for the beneficial effect of minimizing donor-recipient HLA incompatibility, and HLA-DR matching in particular…